Small molecule and monoclonal antibody therapies in neurooncology.
about
Neurotoxicity associated with cancer therapyDacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.Oncogene addiction in gliomas: implications for molecular targeted therapyTargeted brain tumor treatment-current perspectives
P2860
Small molecule and monoclonal antibody therapies in neurooncology.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Small molecule and monoclonal antibody therapies in neurooncology.
@ast
Small molecule and monoclonal antibody therapies in neurooncology.
@en
type
label
Small molecule and monoclonal antibody therapies in neurooncology.
@ast
Small molecule and monoclonal antibody therapies in neurooncology.
@en
prefLabel
Small molecule and monoclonal antibody therapies in neurooncology.
@ast
Small molecule and monoclonal antibody therapies in neurooncology.
@en
P2860
P1433
P1476
Small molecule and monoclonal antibody therapies in neurooncology.
@en
P2093
Nicholas Butowski
Susan M Chang
P2860
P304
P356
10.1177/107327480501200207
P577
2005-04-01T00:00:00Z